Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University have designed a new way to deliver pancreatic cancer drugs that could make fighting the disease much easier. Encapsulating ...
Jan 28, 2021
0
32
Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the long term. Main causes for ...
Jan 25, 2021
0
4
While the public focus remains on COVID vaccines, the Therapeutic Goods Administration (TGA) continues to evaluate a range of proposals around the provision of medical treatments in Australia.
Jan 25, 2021
1
4
Cancer is a major, worldwide challenge, and its impact is projected to escalate due to aging and growth of the population. Researchers recognize that new approaches to diagnose and treat deadly cancers, including identifying ...
Jan 22, 2021
0
48
Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant ...
Jan 19, 2021
0
70
The COVID-19 pandemic has highlighted stark inequalities in healthy life expectancy, according to a report into healthy aging published today.
Jan 15, 2021
0
2
New research from Swansea University suggests that a simple nurse- or carer-led medicines' monitoring system can help reduce medication-related illness for people living in residential care homes—and the process takes just ...
Jan 11, 2021
0
2
Pharmaceutical firms must be "very transparent" about the risks and benefits of vaccines in efforts to end the coronavirus pandemic, the head of Asia's largest drugmaker has told AFP.
Dec 20, 2020
0
3
Since time immemorial, people have been fascinated by ways to stop aging. Nearly every culture has stories to tell about people who lived for thousands of years, showing that extending lifespan has always been a deep desire ...
Dec 18, 2020
0
46
Several drugs already approved by the U.S. Food and Drug Administration (FDA) could potentially be used to alleviate the symptoms of COVID-19, biomedical researchers at Université de Montréal have found.
Dec 17, 2020
0
14
